Innoviva (INVA) Current Deferred Revenue (2016 - 2025)
Innoviva's Current Deferred Revenue history spans 12 years, with the latest figure at $4.3 million for Q4 2025.
- For Q4 2025, Current Deferred Revenue rose 279.22% year-over-year to $4.3 million; the TTM value through Dec 2025 reached $4.3 million, up 279.22%, while the annual FY2025 figure was $4.3 million, 279.22% up from the prior year.
- Current Deferred Revenue reached $4.3 million in Q4 2025 per INVA's latest filing, down from $13.6 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $13.6 million in Q3 2025 to a low of $717000.0 in Q3 2024.
- Average Current Deferred Revenue over 4 years is $2.8 million, with a median of $1.8 million recorded in 2022.
- Peak YoY movement for Current Deferred Revenue: tumbled 73.72% in 2024, then skyrocketed 1792.75% in 2025.
- A 4-year view of Current Deferred Revenue shows it stood at $2.1 million in 2022, then crashed by 39.02% to $1.3 million in 2023, then dropped by 11.82% to $1.1 million in 2024, then skyrocketed by 279.22% to $4.3 million in 2025.
- Per Business Quant, the three most recent readings for INVA's Current Deferred Revenue are $4.3 million (Q4 2025), $13.6 million (Q3 2025), and $3.1 million (Q2 2025).